Your browser doesn't support JavaScript. Please upgrade to a modern browser or enable JavaScript in your existing browser.
Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov

Table 6.9. Threshold Radioactive Exposures and Recommended Prophylactic Single Doses of KI

Patients by Age/Sex Predicted Thyroid
Exposure (Gy)
KI Dose (mg) No. of 130-mg
tablets
No. of 65-mg
tablets
Adults
>40 yr old
>5 130 1 2
Adults
18-40 yr
>0.1 130 1 2
Pregnant or lactating women >0.05 130 1 2
Adolescents 12-18 yr old >0.05 130 1 2
Children
3-12 yr old
>0.05 >65 1/2 1
Children
1 mo to 3 yr old
>0.05 32 1/4 1/2
Neonates
birth to 1 mo old
>0.05 16 1/8 1/4

Source: Adapted from U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research. Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies. Available at http://www.fda.gov/cder/guidance/4825fnl.htm.

Return to Document

 

AHRQ Advancing Excellence in Health Care